Journal article
Bromodomain-containing proteins in prostate cancer.
- Abstract:
-
Several oncogenic factors have been involved in prostate cancer progression. However, therapeutic approaches still focus on suppression of androgen receptor (AR) signaling. In fact, whereas the full-length AR incorporates a ligand-binding domain, which has become a drug target for competitive inhibitors, other transcription factors often do not have tractable binding pockets that aid drug development. Consequently drug development efforts have turned to transcription co-regulators, often chro...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Southern and Eastern Norway Regional Health Authority
More from this funder
Norwegian Centre for Molecular Medicine
More from this funder
South-East Norway Health Authorities
More from this funder
Norwegian Research Council
More from this funder
Norwegian Cancer Society
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Molecular and cellular endocrinology Journal website
- Publication date:
- 2017-06-01
- Acceptance date:
- 2017-06-08
- DOI:
- EISSN:
-
1872-8057
- ISSN:
-
0303-7207
- Pmid:
-
28624514
- Source identifiers:
-
817467
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:817467
- UUID:
-
uuid:710b52a7-ef4a-4ffc-910e-7a22979e1441
- Local pid:
- pubs:817467
- Deposit date:
- 2018-01-11
Terms of use
- Copyright date:
- 2017
If you are the owner of this record, you can report an update to it here: Report update to this record